Gilvetmab
Product Specifications
CAS Number
1808081-43-7
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint|||Immunology/Inflammation|||Apoptosis
Purity
0.979
Bioactivity
Gilvetmab is a caninized anti-PD-1 monoclonal antibody that has obtained conditional approval for veterinary use in dogs. Gilvetmab is under active research for stage I, II, or III mast cell tumors and stage II or III melanoma. it is an competitive immune checkpoint inhibitor, attracting interests in the cancer research field.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6240689-01 0.1 mL
SOCS3 (Suppressor of Cytokine Signaling 3, ATOD4, CIS3, Cish3, MGC71791, SOCS-3, SSI-3, SSI3) (MaxLight 750)
Ask
View Details MBS6240689-02 5x 0.1 mL
SOCS3 (Suppressor of Cytokine Signaling 3, ATOD4, CIS3, Cish3, MGC71791, SOCS-3, SSI-3, SSI3) (MaxLight 750)
Ask
View Details 